Changing CG landscape with CFTR modular therapy

With cystic fibrosis (CF) being a life course disease, this talk provides an overview of CF in paediatrics to adult, and delves into testing, therapies including Cystic fibrosis transmembrane conductance regulator (CFTR), new transformational era modulators and challenges for those with CF.

• Different classes of CFTR mutations
• Pathophysiology
• Drug development pipeline
• Extending benefits to younger populations
• Reducing treatment burden
• Review the current challenges that still remain

Professor Jane Davies is a consultant in paediatric respiratory medicine, specialising in cystic fibrosis (CF), nasal potential difference (nPD) and clinical trials.

Learn more about Professor Jane Davies, her research interests, publications and teaching here.

Professor Nicholas Simmonds is associate director and consultant physician of the Adult Cystic Fibrosis Centre at Royal Brompton, and professor of practice (respiratory medicine) at the National Heart and Lung Institute, Imperial College London.

Learn more about Professor Nicholas Simmonds, his clinical expertise, research interests and publications here.